5 funding opportunities are listed in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest
Sheiner-Beal Pharmacometrics Award
Each year, the American Society for Clinical Pharmacology and Therapeutics Scientific Awards Program seeks to recognize outstanding science in clinical pharmacology. ASCPT Awards span the continuum of clinical pharmacology and recognize every turning point in the career path from young investigator to seasoned scientist.
The deadline to submit a nomination is September 24, 2010 at 4:00pm ET.
The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics.
Definition Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiology, genetic constitution and/or disease for quantitative analysis of interactions between drugs and patients. The domain of pharmacometrics includes the application of techniques that address the interactions between pharmacokinetics, pharmacodynamics, pharmacogenomics and disease progression with a focus on populations and variability in the exposure-response relationship.
Goal The goal of the Sheiner-Beal Pharmacometrics Award is to recognize outstanding achievements at the forefront of research or leadership in pharmacometrics and/or application of pharmacometric concepts and techniques to enhance research, development, regulatory evaluation and/or utilization of therapeutic products.
Eligibility The candidate must be an investigator or leader who is actively advancing the scientific discipline of pharmacometrics and/or its impact on research, development, regulatory evaluation, or utilization of therapeutic products, and is capable of delivering an engaging and comprehensive lecture on pharmacometrics. The award is intended to recognize clinical pharmacologists, clinician scientists, computational scientists, statisticians and others in academia, industry, government agencies or consulting whose work falls within the scope of the definition of pharmacometrics.
Prize and Presentation The Sheiner-Beal Pharmacometrics Award will be presented bi-annually at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient will receive a $1,500 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
For more information about the Sheiner-Beal Pharmacometrics Award, please contact ASCPT at (703) 836-6981 or meetings@ascpt.org.
PhRMA Foundation Research Starter Grants in Pharmaceutics
Application Deadline : 10-01-2010
The purpose of the PhRMA Foundation Research Starter Grants is to offer financial support to individuals beginning their independent research careers at the faculty level. The areas of interest within this program are research efforts in the fields of pharmaceutics. The program provides a research grant of $60,000 for one year.
Research projects that extend or develop the proprietary value of specific drug products are not acceptable in this program. This exclusion does not preclude research in which specific drug products are used to test hypotheses that have a general applicability.
For the purposes of this program, pharmaceutics includes basic pharmaceutics, biopharmaceutics, pharmaceutical technology and pharmaceutical biotechnology. The fundamental aspects of pharmacokinetics are not included since they are covered by PhRMA Foundation programs in pharmacology and toxicology. It is anticipated that this research experience will occur in an academic and/or industrial laboratory setting.
The "starter" aspect of the program strives to assist those individuals who are establishing careers as independent investigators in the fields listed above. The program is not offered as a means to augment an ongoing research effort. Nor is the grant intended to be used for any direct effort to obtain further extramural funding. The funds are to be used to conduct the proposed research. This program supports individuals beginning independent research careers in academia who do not have other substantial sources of funding.
Funds are generally unrestricted, with flexibility of use - a characteristic of the program. In an effort to gain the maximum usefulness, some guidelines are in order. The funds may not be used for salary support of the grantee, but may be used to support technical assistance. No more than $500 a year may be used for travel to professional meetings by the grantee. Indirect costs are not provided to the institution, and grant funds may not be used for this purpose. These funds are not transferrable.
Applications, however good, which do not meet the aims of the program will be disapproved.
Eligibility
Those holding the academic, tenure track, rank of instructor or assistant professor and investigators at the doctoral level with equivalent positions are eligible to apply for these research starter grants, providing their proposed research is neither directly nor indirectly subsidized to any significant degree by an extramural support mechanism. Individuals holding non-tenure track positions, such as Research Assistant Professor or Visiting Assistant Professor, are not eligible to apply. The program is not intended for those in postdoctoral training programs. However, individuals in postdoctoral training scheduled to conclude, and who will hold an academic appointment, by January 1, 2011 may apply. Applicants must be sponsored by the department or unit within which the proposed research is to be undertaken. The grant is made to the university on behalf of the applicant and with the understanding that the university will administer the funds. Only schools of pharmacy are eligible for this award.
Applications must be submitted by a school of pharmacy accredited by the American Council on Pharmaceutical Education, and all applicants must be U.S. citizens or permanent residents. Applications are to be submitted via the Foundation website and received by October 1, 2010. Applications will not be accepted after the deadline date.
Applicants will be judged on the scientific worthiness of the proposed research, and on the degree of need. If support is obtained after the application has been submitted, the Foundation must be so informed.
Before an individual is eligible to apply for a PhRMA Foundation award, the applicant must first have a firm commitment from a U.S. university.
These grants will begin on January 1, 2011 for a period of 1 year.
PhRMA Foundation 950 F Street, N.W. Suite 300 Washington, DC 20004
Phone: 202-572-7756 Fax: 202-572-7799
PhRMA Foundation Sabbatical Fellowships in Pharmaceutics
This program provides stipend funding to enable pharmaceutics faculty members at all levels with active research programs the opportunity to work at other institutions for periods of from six months to one year to learn new skills or develop new collaborations that will enhance their research and research training activities in pharmaceutics. Applicants are expected to have approval (or pending approval) for a sabbatical leave from their home institution, and provide an endorsement from the mentor who will sponsor their sabbatical activity. Matching funds must be provided through the university.
Matching funds must be provided by the home institution.
Eligible applicants must (1) hold a PhD, Pharm.D., M.D. or Sc.D. degree in a field of study logically or functionally related to the proposed post doctoral activities, (2) hold a faculty appointment that imparts eligibility for a sabbatical leave from their home institution, (3) have institutional approval of a sabbatical plan that includes partial salary that matches the PhRMA stipend, (4) hold an endorsement from a mentor who agrees to sponsor the applicant's visiting scientist activity, and (5) be a U.S. citizen or permanent resident. Applications are to be submitted via the Foundation website and received by October 1, 2010. Applications will not be accepted after the deadline date.
Award
Provides up to $40,000 stipend support for mid-career scientists to engage in an academic year or calendar year experiential program intended to redirect their core research focus to an area of emerging importance to pharmaceutical research and development. The program provides no other subsidies (travel, tuition, fringe benefit costs, etc.) and indirect costs to the institution are not provided. It is expected that the fellowship will be administered in accordance with the prevailing policies and procedures of the institution. Successful applicants will have approval for a sabbatical leave from their home institution, and a commitment to host their experience from a research mentor in an environment other than the applicant's home institution. These funds are not transferrable.
NOTE: Awards may be activated beginning January 1, 2011 or on the first day of any month thereafter, up to and including December 1, 2011.
PhRMA Foundation Post Doctoral Fellowships in Pharmaceutics
Pharmaceutics is that area of the pharmaceutical sciences that seeks the optimal development of a drug delivery product or device and its subsequent performance in the delivery of the drug from the device following its administration to a patient. Pharmaceutics is a multidisciplinary area, with significant underpinnings from such basic scientific disciplines as physical chemistry, physical organic chemistry, and biophysics.
The number of well-trained graduates from Ph.D. programs in pharmaceutics who further develop and refine their research skills through formal postdoctoral training is limited. The reasons for this frequent absence of postdoctoral research experience are several. They include strong employment demand by industry and academia for junior scientists when they graduate from doctoral programs and a shortage of funds available to universities for the ready support of postdoctoral fellows. This situation serves to compromise the ultimate research capabilities of many such graduates. The lack of postdoctoral experience can be particularly telling for Ph.D. graduates seeking academic positions and often renders them less competitive in the successful pursuit of extramural funding - a factor which is so necessary for a productive research program.
The PhRMA Foundation recognizes the critical need for such well-trained scientific investigators. Accordingly, it wishes to encourage more qualified graduates to obtain postdoctoral research training in pharmaceutics. The Foundation seeks to achieve this goal by providing fellowships each year to qualified applicants who have the opportunity to become involved with mentors, facilities and programs that, collectively, can be expected to provide an excellent environment for the fellow. Applications will be accepted for postdoctoral research training extending over a minimum of one year and a maximum of two years. Each fellowship carries an annual stipend of $40,000 which can be supplemented by the sponsor and/or his/her institution.
To be eligible, applicants must either (i) hold a Ph.D. degree in pharmaceutics or a related discipline from an accredited U.S. university or (ii) expect to receive such a degree before activating the fellowship. The mentor of the fellow must be in an accredited school of pharmacy. Alternatively, a student with a Ph.D. from a school of pharmacy may use the fellowship to study with a mentor in any science or engineering department. Applicants should indicate a strong determination to continue their research careers in pharmaceutics following completion of the fellowship. An equally important aspect of eligibility is that suitable facilities for the necessary training and research must be available to the applicant. The program with which the applicant is, or will be, associated must provide an environment where the applicant's potential can be developed to the fullest extent possible.
Before an individual is eligible to apply for a PhRMA Foundation award, the applicant must first have a firm commitment from a university in the U.S. Applications must be submitted by an accredited U.S. school and all applicants must be U.S. citizens or permanent residents. Applications are to be submitted via the Foundation website and received by October 1, 2010. Applications will not be accepted after the deadline date.
Purpose
For the purposes of this program, pharmaceutics includes basic pharmaceutics, biopharmaceutics, pharmaceutical technology and pharmaceutical biotechnology. Ph.D. graduates in chemistry, physics, biology and related areas who wish to develop expertise and careers in pharmaceutics through relevant post-doctoral experience are also encouraged to apply. The fundamental aspects of pharmacokinetics are not included since these are covered by PhRMA Foundation programs in pharmacology and toxicology. The focus of the program is to assist in the postdoctoral research training of the applicant. It should be stressed that the quality of the research proposed will be a major factor in the selection of fellows. Research projects that extend or develop the proprietary value of specific drug products are not acceptable in this program. This exclusion does not preclude research in which specific drug products are used to test hypotheses which have a general applicability.
The award, consisting of a $40,000 annual stipend, is made to the institution on behalf of the fellow. Awards may be activated beginning January 1, 2011 or on the first day of any month thereafter, up to and including December 1, 2011. The award is intended solely as a stipend and may not be used otherwise. If necessary, the institution may supplement the award to a level that is consistent with other postdoctoral fellowships it currently offers. If the stipend is to be supplemented, indicate the amount. If no supplement is intended, so state this. The program provides no other subsidies (travel, tuition, fringe benefit costs, etc.) and indirect costs to the institution are not provided. It is expected that the fellowship will be administered in accordance with the prevailing policies and procedures of the institution.
The second year of this award is contingent upon a progress report approved by the Foundation and submission of a financial report. These funds are not transferrable.
PhRMA Foundation Pre Doctoral Fellowships in Pharmaceutics
Progress in pharmaceutics research requires the constant entry of well-trained investigators into the field. The PhRMA Foundation recognizes the critical need for such scientists and appreciates that the training of such individuals is both long and expensive, requiring four to five years of study and research. To encourage the entry of more qualified individuals into this area, the PhRMA Foundation program aims at supporting promising students during their thesis research by providing assistance in the form of stipend and funds to cover costs incidental to the training. Applications will be accepted for a minimum of one year and a maximum of two years.
The program is designed for applicants who expect to complete the requirements for the Ph.D. in pharmaceutics in two years or less from the time the fellowship begins. For the purposes of this program, pharmaceutics includes basic pharmaceutics, biopharmaceutics and pharmaceutical technology. The fundamental aspects of pharmacokinetics are not included since these are covered by PhRMA Foundation awards in pharmacology and toxicology. Students in this area are encouraged to submit an application to that program.
The program assumes that the fellows will devote full-time (including summers) to their research. The PhRMA Foundation fellowship may not be used as a supplement to funds from other fellowships or assistantships. However, this does not preclude institutions supplementing a fellowship with their own funds in order to bring the stipend within the normal range of the institution. The focus of the program is to assist in the predoctoral training of the applicant. It should not be viewed as a program to fund a research project. It should be stressed that the quality of the research proposed will be a major factor in the selection of fellows. The student's success in carrying out a rigorous academic [i.e., course work] program will be another major selection factor. Research projects which extend or develop the proprietary value of specific drug products are not acceptable in this program. This exclusion does not preclude research in which specific drug products are used to test hypotheses which have a general applicability. Applications, however good, which do not meet the aims of the program will be disapproved.
The fellowship program of pre doctoral support is designed to assist full-time, in-residence Ph.D. candidates in pharmaceutics who are enrolled in a school of pharmacy accredited by the American Council on Pharmaceutical Education or the mentor of the applicant must be in an accredited school of pharmacy. The program seeks to support advanced students who will have completed the bulk of their pre-thesis requirements (generally two years of study) and are starting their thesis research by the time the award is activated. Students just starting in graduate school should not apply.
To be eligible, applicants must hold a B.S., M.S., or Pharm.D. degree in pharmacy or a related area such as chemistry or biology from an accredited school in the U.S. A candidate enrolled in a Pharm.D./Ph.D. program should not be taking required clinical course work or clinical clerkships during the tenure of the fellowship. Also, before an individual is eligible to apply for a PhRMA Foundation award, the applicant must first have a firm commitment from a U.S. university, and must be a U.S. citizen or permanent resident. Applications are to be submitted via the Foundation website and received by October 1, 2010. Applications will not be accepted after the deadline date.
The award is made to the university on behalf of the fellow. The fellowship provides a stipend of $20,000 a year payable monthly for a minimum of one year and a maximum of two years. Of the $20,000 awarded annually, up to $500 a year may be used for incidentals directly associated with the thesis research preparation (e.g., secretarial help, artwork, books, travel, etc.). Awards may be activated beginning January 1, 2011 or on the first day of any month thereafter, up to and including August 1, 2011. The second year of funding, if applicable, will be contingent upon a satisfactory review of the award recipient's progress during the first ten months of funding. A progress report will be due to the Foundation prior to the beginning of the second year of funding. The progress will be assessed by the Informatics Advisory Committee. The decision will be based on adherence to the goals of the announcement of the overall program, and also in keeping with the originally proposed research on which the award was based. In addition to the progress report, the Foundation must receive certification from the thesis advisor that satisfactory progress is being achieved.
The program, therefore, is designed to provide students stipend support during thesis research. An individual may not simultaneously hold or interrupt any other fellowship providing stipend support during the PhRMA Foundation fellowship. During the tenure of the fellowship, the fellow must be a full-time in-residence student. These funds are not transferrable.
The stipend may be continued for up to three months after completion of the requirements for the doctorate, provided that the student remains in the department during this period and has obtained no other stipend or salary support. This provision applies only if there is sufficient time remaining within the agreed upon period of the fellowship and upon specific request to the Foundation, detailing how the time would be used.
Indirect costs are not provided to the institution and PhRMA Foundation grant funds may not be used for this purpose.
1